Cathay Biotech Inc (688065)

Currency in CNY
53.45
-0.55(-1.02%)
Closed·
688065 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
53.2655.69
52 wk Range
43.0764.50
Key Statistics
Bid/Ask
53.45 / 53.47
Prev. Close
54
Open
53.45
Day's Range
53.26-55.69
52 wk Range
43.07-64.5
Volume
7.52M
Average Volume (3m)
5.41M
1-Year Change
8.308%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688065 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
62.95
Upside
+17.77%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Cathay Biotech Inc Company Profile

Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally. The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands. It also provides digital solutions for electrification, automation, and digitization for biological manufacturing. The company’s products are used in textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, engineering materials, and other industries. It exports its products. The company was incorporated in 2000 and is headquartered in Shanghai, China.

Industry
Chemicals
Employees
1735
Market
China

Compare 688065 to Peers and Sector

Metrics to compare
688065
Peers
Sector
Relationship
P/E Ratio
65.5x51.3x4.8x
PEG Ratio
1.880.130.00
Price/Book
2.2x3.8x1.6x
Price / LTM Sales
11.8x5.7x1.4x
Upside (Analyst Target)
16.6%7.5%20.1%
Fair Value Upside
Unlock1.0%−0.3%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 62.95
(+17.77% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.92%
Dividend Yield
0.74%
Industry Median 1.21%
Annualized payout
0.40
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 31, 2025
EPS / Forecast
0.20 / --
Revenue / Forecast
874.00M / --
EPS Revisions
Last 90 days

688065 Income Statement

People Also Watch

23.77
600346
-8.65%
25.69
600862
+0.51%
17.65
600143
-0.68%
81.03
600486
+1.30%

FAQ

What Is the Cathay Biotech (688065) Stock Price Today?

The Cathay Biotech stock price today is 53.45 CNY.

What Stock Exchange Does Cathay Biotech Trade On?

Cathay Biotech is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for Cathay Biotech?

The stock symbol for Cathay Biotech is "688065."

Does Cathay Biotech Pay Dividends? What’s The Current Dividend Yield?

The Cathay Biotech dividend yield is 0.74%.

What Is the Cathay Biotech Market Cap?

As of today, Cathay Biotech market cap is 38.92B CNY.

What Is Cathay Biotech's Earnings Per Share (TTM)?

The Cathay Biotech EPS (TTM) is 0.92.

When Is the Next Cathay Biotech Earnings Date?

Cathay Biotech will release its next earnings report on Apr 24, 2026.

From a Technical Analysis Perspective, Is 688065 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Cathay Biotech Stock Split?

Cathay Biotech has split 1 times.

How Many Employees Does Cathay Biotech Have?

Cathay Biotech has 1735 employees.

What is the current trading status of Cathay Biotech (688065)?

As of Mar 04, 2026, Cathay Biotech (688065) is trading at a price of 53.45 CNY, with a previous close of 54.00 CNY. The stock has fluctuated within a day range of 53.26 CNY to 55.69 CNY, while its 52-week range spans from 43.07 CNY to 64.50 CNY.

What Is Cathay Biotech (688065) Price Target According to Analysts?

The average 12-month price target for Cathay Biotech is 62.95 CNY, with a high estimate of 64.9 CNY and a low estimate of 61 CNY. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +17.77% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.